Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
AssigneeAbbVie Deutschland GmbH & Co. KG
InventorsThorsten Oost, Astrid Netz, Hervé Geneste, Wilfried Braje, Wolfgang Wernet, Liliane Unger, Wilfried Hornberger, Wilfried Lubisch
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel amidomethyl-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders.
Claims29
A compound of the formula I
- in which
- R1 is hydrogen, methoxy or ethoxy;
- R2 is hydrogen or methoxy;
- R3 is hydrogen, methyl, ethyl, n-propyl or isopropyl;
- X1 and X2 are N or CH, with the proviso that X1 and X2 are not simultaneously N;
- and their pharmaceutically acceptable salts and prodrugs thereof.
A compound as claimed in any of the preceding claims, in which R3 is hydrogen, methyl or ethyl.
A compound as claimed in any of the preceding claims, in which X1 is N and X2 is CH.
A compound as claimed in any of the preceding claims, in which
- R1 is methoxy;
- R2 is methoxy;
- R3 is methyl;
- X1 is CH;
- and
- X2 is N.
A compound as claimed in any of the preceding claims, which is the (−) enantiomer in an enantiomeric purity of at least 50% ee.
A pharmaceutical composition comprising at least one compound of the formula I as defined in any of the preceding claims and/or at least one pharmaceutically acceptable salt or prodrug thereof and at least one pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.